| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2013.09.024 |
| P698 | PubMed publication ID | 24099870 |
| P2093 | author name string | Xiaoming Li | |
| Kang Liu | |||
| Chunyi Xue | |||
| Yongchang Cao | |||
| Lijuan Yin | |||
| Lishan Lv | |||
| Genmei Liu | |||
| Dongu Luo | |||
| P2860 | cites work | Assembly of the coronavirus envelope: homotypic interactions between the M proteins | Q27469592 |
| Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. | Q30404941 | ||
| The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles | Q30484261 | ||
| The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex | Q33782199 | ||
| Self-assembly of severe acute respiratory syndrome coronavirus membrane protein | Q33800043 | ||
| Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles | Q33803912 | ||
| Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin | Q34576871 | ||
| Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. | Q35848639 | ||
| Protein interactions during coronavirus assembly | Q36548807 | ||
| The molecular biology of coronaviruses | Q36550910 | ||
| Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production | Q37596633 | ||
| Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development | Q38059059 | ||
| Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein | Q39588413 | ||
| Analysis of severe acute respiratory syndrome coronavirus structural proteins in virus-like particle assembly. | Q39899118 | ||
| Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly | Q40107532 | ||
| Assembly of human severe acute respiratory syndrome coronavirus-like particles | Q40555020 | ||
| Reconstitution of the fusogenic activity of vesicular stomatitis virus. | Q41827323 | ||
| Functional reconstitution of influenza virus envelopes | Q42952236 | ||
| Location of antigenic sites defined by neutralizing monoclonal antibodies on the S1 avian infectious bronchitis virus glycopolypeptide | Q43440977 | ||
| The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction | Q44235724 | ||
| Immune responses to structural proteins of avian infectious bronchitis virus | Q45392761 | ||
| Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes | Q45411655 | ||
| Structural proteins of avian infectious bronchitis virus: role in immunity and protection | Q45778056 | ||
| The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens | Q45782049 | ||
| Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection | Q45836578 | ||
| Antigenic domains on the peplomer protein of avian infectious bronchitis virus: correlation with biological functions | Q45860091 | ||
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bronchitis | Q173022 |
| infectious bronchitis virus | Q69459596 | ||
| P304 | page(s) | 5524-5530 | |
| P577 | publication date | 2013-10-05 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins | |
| P478 | volume | 31 |
| Q63246352 | Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus |
| Q30373411 | Genomic and single nucleotide polymorphism analysis of infectious bronchitis coronavirus. |
| Q39517034 | Immunogenicity and protective efficacy of recombinant fusion proteins containing spike protein of infectious bronchitis virus and hemagglutinin of H3N2 influenza virus in chickens |
| Q58763616 | Novel coronavirus-like particles targeting cells lining the respiratory tract |
| Q33865400 | Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus |
| Q59357962 | Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins |
| Q40040336 | Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q38559055 | Supramolecular Architecture of the Coronavirus Particle |
| Q40566186 | Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection |
| Q38388047 | The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors |
Search more.